Cefepime-Enmetazobactam Shows Promise for ESBL-Producing Enterobacteriaceae
The novel drug combines a fourth-generation cephalosporin with a novel extended-spectrum β-lactamase inhibitor.
Read More
Fosfomycin Does Not Demonstrate Non-Inferiority for E. Coli. Bacteremic UTI
Drug resistance has physicians racing to find alternative therapies for many infections. In a new non-inferiority study, fosfomycin was inferior to more common therapies.
Gram-Negative Infections Successfully Treated with Ceftazidime-Avibactam
Gram-negative bacteria can cause infections, are resistant to multiple drugs, and are increasingly resistant to most available antibiotics, the CDC says.
